Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2630
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy ; day:4 ; month:10 ; year:2019 ; pages:1-8
International ophthalmology ; (4.10.2019), 1-8
- Creator
-
Castagna, I.
Roszkowska, A. M.
Alessandrello, F.
Oliverio, G. W.
Tumminello, G.
Gallizzi, R.
Conti, G.
Aragona, P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10792-019-01184-8
- URN
-
urn:nbn:de:101:1-2020020801115385767809
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Castagna, I.
- Roszkowska, A. M.
- Alessandrello, F.
- Oliverio, G. W.
- Tumminello, G.
- Gallizzi, R.
- Conti, G.
- Aragona, P.
- SpringerLink (Online service)
Other Objects (12)
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Juvenile Spondyloarthritis: focus on uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
P01-005 – Idiopathic uveitis and FMF
“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature”
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Juvenile Spondyloarthritis: focus on uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
P01-005 – Idiopathic uveitis and FMF
“Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature”
Juvenile idiopathic arthritis-associated uveitis
Juvenile Uveitis
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Perinatal events and development of juvenile idiopathic arthritis-associated uveitis
Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Juvenile Spondyloarthritis: focus on uveitis
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Knowledge about juvenile idiopathic arthritis-associated uveitis: more frequent reminders are associated with higher patient and family uveitis knowledge
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
P01-005 – Idiopathic uveitis and FMF